Filtered By:
Management: Medicaid
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 545 results found since Jan 2013.
Reducing Cancer Care Costs and Hospital Stays
There are two really irritating things about cancer care for me. (Well there are really lots of things that irritate me about cancer care. I could make a giant list of them if anyone really cared but today I am going to focus on two things.Cancer care is ridiculously expensive. You can take a drug for $100,000 that might increase your lifespan for a couple of months. A single chemo infusion can cost upwards of $20,000.And at the least sign of germs or low blood counts, you are sent to the emergency room where they admit you. That is a really stupid part. You feel like crap on a Friday night, you call your oncologist and th...
Source: Caroline's Breast Cancer Blog - November 13, 2016 Category: Cancer & Oncology Tags: cancer care cancer costs hospital Source Type: blogs
National Minority Health Month Is A Call To Action
April is National Minority Health Month.
That's the "dry" statement. The impact statement is that-unfortunately-for many in this country, this is more than a phrase. It's a reality that their health and their health care are in crisis. And the sooner more of us understand this, the sooner we can make a genuine effort to implement effective strategies that will address the sad state of affairs many people find themselves in when it comes to their health, and preventing and appropriately treating their diseases.
This is about more than high blood pressure and diabetes. It's about heart disease and stroke and cancer and the l...
Source: Dr. Len's Cancer Blog - April 18, 2013 Category: Cancer Authors: Dr. Len Tags: Access to care Breast Cancer Cancer Care Cervical Cancer Colon Cancer Early detection Environment Prevention Screening Survivors Treatment Source Type: blogs
Breast Cancer Patients Deserve Better: Policy Must Support Innovation
October is National Breast Cancer Awareness Month. During this time, those of us in the advocacy community take stock of the millions of lives that have been affected forever by this dreadful disease. Breast cancer ranks second as a cause of death in women. Each year, about 230,000 women, and more than 2,000 men, receive a diagnosis of invasive breast cancer.
Cancer survivors, caregivers and doctors tell us that the most powerful weapons against breast cancer are early detection and the elimination of “trial and error” therapies. This is accomplished by pinpointing the most effective treatment options immediately after...
Source: Disruptive Women in Health Care - October 31, 2013 Category: Health Medicine and Bioethics Commentators Authors: dw at disruptivewomen.net Tags: Uncategorized Source Type: blogs
The Dangers of Big Corporate Health Care: Deceptive Marketing of Cancer Treatments
A series of articles over the last few months, culminating in an investigative report by Reuters, provided the newest example of what can go wrong when corporations provide direct care to vulnerable patients. In this case, the vulnerable patients had cancer, and the corporation that provided them care was the Cancer Treatment Centers of America (CTCA). I will try to go through the case chronologically.As Rueters reported, CTCA "was founded in 1988 by Richard J. Stephenson, who has been chairman ever since."The Founder's Checkered PastA Misdemeanor As Reuters noted,A graduate of Northwestern University Law Schoo...
Source: Health Care Renewal - March 11, 2013 Category: Health Medicine and Bioethics Commentators Tags: deception crime marketing Cancer Treatment Centers of America hospital systems complementary/ alternative medicine Source Type: blogs
Colon cancer screening: Is there an easier, effective way?
Are you, or is someone you know, postponing their colonoscopy? Maybe it’s the idea of that prep. At best, it requires being home and near a toilet for a day. Worse, it can make people feel awfully ill. Or maybe it’s the invasiveness of the test. At best, it’s unpleasant. At worst, there can be serious complications, including an instrument puncturing the bowel, bleeding, and organ damage. It’s also time-consuming, requiring time off work for you and whoever will be driving you home.
Why is a colonoscopy worth the hassle?
Cancers of the colon and rectum are common, and lives can be saved with early detection. Colore...
Source: Harvard Health Blog - December 5, 2016 Category: Consumer Health News Authors: Monique Tello, MD, MPH Tags: Cancer Digestive Disorders Health Healthy Aging Screening Source Type: blogs
Building Sustainable Partnerships To Improve Access To Breast Cancer Treatment For Uninsured Women
Breast cancer is a terrifying disease for most women. In the United States, it is the leading cause of cancer deaths among women ages twenty to fifty-nine years. More than 5,100 women are diagnosed with—and at least 1,100 women die from—breast cancer in New York City each year. The breast cancer survival rate is also lower for uninsured women than for those with private health insurance coverage.
Although access to affordable breast cancer screening and treatment has grown substantially over the past few years as a result of increased health insurance coverage options through the Affordable Care Act (ACA), many uninsur...
Source: Health Affairs Blog - June 20, 2017 Category: Health Management Authors: Kumbirai M. Madondo, Janice Zaballero and José Pagán Tags: Costs and Spending Featured GrantWatch Health Professionals Insurance and Coverage Access breast cancer Consumers Health Care Costs Health Care Delivery Health Philanthropy Health Promotion and Disease PreventionGW Hospitals imag Source Type: blogs
Paying For Value In Cancer Care
Everyone wants to pay for value (and certainly not just for volume) and the value imperative is nowhere greater than in cancer care. Cancer care cost the US health care system $125 billion in 2010, accounting for 5 percent of total health care spending. Before Sovaldi hit the front pages for offering a breakthrough treatment for Hepatitis C at a cost of $84,000, and Turing Pharmaceuticals pushed Sovaldi out of the headlines for increasing the price of an HIV drug 50 fold, most of the attention to drug pricing was focused on cancer.
With average yearly treatment costs exceeding $100,000, cancer drugs in the US cost nearly t...
Source: Health Affairs Blog - October 29, 2015 Category: Health Management Authors: Alan Weil Tags: Costs and Spending Drugs and Medical Technology Long-term Services and Supports Medicare Once in a Weil Payment Policy Quality Bundled Payments Cancer ECRI performance payments Primary Care Source Type: blogs
We Could Now See Cervical Cancer Rates Increase
By ILANA ADDIS, MD
In 2014 I took my first trip to Kenya. After my plane landed in Nairobi I rode for 10 hours with my medical colleagues to Bungoma, a town on the western edge of the country. We set up our clinic in the local hospital and then spent the week training local healthcare providers on a technique called ‘Visual Inspection with Acetic Acid (VIA)’. This is an inexpensive method to screen for cervical cancer and pre-cancer in low resource settings using vinegar. As a part of the training we screened 189 women for cervical cancer in that week.
The Papaniculou (pap) smear was revolutionary in cervical cancer pr...
Source: The Health Care Blog - May 4, 2017 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Cervical Cancer MacArthur Amendment Source Type: blogs
Thanks to the AHCA We Could Now See Cervical Cancer Rates Increase
By ILANA ADDIS, MD
In 2014 I took my first trip to Kenya. After my plane landed in Nairobi I rode for 10 hours with my medical colleagues to Bungoma, a town on the western edge of the country. We set up our clinic in the local hospital and then spent the week training local healthcare providers on a technique called ‘Visual Inspection with Acetic Acid (VIA)’. This is an inexpensive method to screen for cervical cancer and pre-cancer in low resource settings using vinegar. As a part of the training we screened 189 women for cervical cancer in that week.
The Papaniculou (pap) smear was revolutionary in cervical cancer pr...
Source: The Health Care Blog - May 4, 2017 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Cervical Cancer MacArthur Amendment Source Type: blogs
African American and white men who receive comparable treatments for prostate cancer have similar survival
Last year, we reported on two studies showing that African American men respond at least as well as white men to prostate cancer treatments given in clinical trials. Nationally, African Americans with prostate cancer are more than twice as likely to die of the disease as their white counterparts, and that has fueled speculation that genetic or biological factors put them at greater risk. But according to this new research, the survival difference disappears when men of either race get the same cutting-edge treatments.
Now scientists are reporting that African American and white men with prostate cancer live equally as long...
Source: Harvard Health Blog - February 13, 2020 Category: Consumer Health News Authors: Charlie Schmidt Tags: Health Living With Prostate Cancer Prostate Knowledge Treatments HPK Source Type: blogs
Yes, Providing Cancer Drugs In Multiple Vial Sizes Could Save Patients and Payers Money
On March 1, 2016, we published an article in the BMJ showing how in the US nearly $3 billion will be spent on discarded cancer drugs this year because companies package drugs in vials that contain too much of the drug for most doses, creating expensive leftover product. We proposed that companies in the US should either package drugs in more appropriate vial sizes to reduce the leftover amounts, or provide refunds for leftover drug.
Since the time of our article’s publication, numerous Senators have written letters to the Food and Drug Administration (FDA) urging action on vial sizes, and calling for the Department of He...
Source: Health Affairs Blog - June 8, 2016 Category: Health Management Authors: Peter Bach, Rena Conti, Raymond Muller, Geoffrey Schnorr and Leonard Saltz Tags: Costs and Spending Drugs and Medical Technology Cancer Source Type: blogs
New Evidence in JAMA Shows Insurance Gaps Leave Some Cancer Patients Without
BY BAILEY FITZGERALD
“How long do I have?”
The man was just diagnosed with lung cancer.
“That depends,” his doctor says. “What insurance do you have?”
New research suggests that conversations like these may be actually taking place across the country. Todd Pezzi and colleagues analyzed a national database for treatment outcomes for patients with limited stage non-small cell lung cancer, a diagnosis with high rates of response to treatment. The results, reported in JAMA Oncology last week were astounding: patients with Medicare, Medicaid, or no health insurance received different, and often worse, care than thos...
Source: The Health Care Blog - January 12, 2018 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Bailey Fitzgerald Cancer JAMA Oncology Standard of Care Source Type: blogs
New Evidence in JAMA Shows Insurance Gaps Leave Some Cancer Patients Without Treatment
BY BAILEY FITZGERALD
“How long do I have?”
The man was just diagnosed with lung cancer.
“That depends,” his doctor says. “What insurance do you have?”
New research suggests that conversations like these may be actually taking place across the country. Todd Pezzi and colleagues analyzed a national database for treatment outcomes for patients with limited stage non-small cell lung cancer, a diagnosis with high rates of response to treatment. The results, reported in JAMA Oncology last week were astounding: patients with Medicare, Medicaid, or no health insurance received different, and often worse, care than thos...
Source: The Health Care Blog - January 12, 2018 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Bailey Fitzgerald Cancer JAMA Oncology Standard of Care Source Type: blogs
Lung cancer screening and shared decision making: Will it happen?
Recently, the Centers for Medicare & Medicaid Services (CMS) officially proposed coverage for annual low-dose computed tomography (LDCT) screening for lung cancer in current or former smokers age 55 to 74 years with at least a 30 pack-year history. In doing so, CMS followed the lead of the U.S. Preventive Services Task Force, which had previously given a “B” grade recommendation for screening in a similar population through age 80 years.
Continue reading ...
Your patients are rating you online: How to respond. Manage your online reputation: A social media guide. Find out how.
Source: Kevin, M.D. - Medical Weblog - December 4, 2014 Category: Journals (General) Authors: Kenneth Lin, MD Tags: Conditions Cancer Pulmonology Source Type: blogs
Roger Chou ’s Undisclosed Conflicts of Interest: How the CDC’s 2016 Guideline for Prescribing Opioids for Chronic Pain Lost Its Clinical and Professional Integrity
by Chad D. Kollas MD, Terri A. Lewis PhD, Beverly Schechtman and Carrie Judy“I ' m present. Uh … I do have a conflict. I receive funding to conduct reviews on opioids, and I ' ll be recusing myself after the um, director ' s, uh, um, um, uh … update.”- Dr. Roger Chou, Center for Disease Control and Prevention (CDC) National Center for Injury Prevention and Control (NCIPC) Board of Scientific Counselors (BSC) Meeting Friday, July 16, 2021.IntroductionFor those familiar with the controversial relationship between the anti-opioid advocacy group, Physicians for Responsible Opioid Prescribing (PROP, recently renamed, He...
Source: Pallimed: A Hospice and Palliative Medicine Blog - September 17, 2021 Category: Palliative Care Tags: CDC judy kollas lewis opioid pain schechtman Source Type: blogs
